KR20130091321A - 음료 내의 약물을 검출하기 위한 방법 및 성분 - Google Patents

음료 내의 약물을 검출하기 위한 방법 및 성분 Download PDF

Info

Publication number
KR20130091321A
KR20130091321A KR1020137003073A KR20137003073A KR20130091321A KR 20130091321 A KR20130091321 A KR 20130091321A KR 1020137003073 A KR1020137003073 A KR 1020137003073A KR 20137003073 A KR20137003073 A KR 20137003073A KR 20130091321 A KR20130091321 A KR 20130091321A
Authority
KR
South Korea
Prior art keywords
pharmaceutical formulation
fcf
particles
green
beverage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137003073A
Other languages
English (en)
Korean (ko)
Inventor
캐서린 헤리
파울린 콘타민
엠마뉴엘 두파우
Original Assignee
에씨팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에씨팜 filed Critical 에씨팜
Publication of KR20130091321A publication Critical patent/KR20130091321A/ko
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020137003073A 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분 Ceased KR20130091321A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1055490A FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
FR1055490 2010-07-06
PCT/FR2011/051600 WO2012010765A1 (fr) 2010-07-06 2011-07-05 Methode et agent pour la detection de drogues dans les boisson

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187019307A Division KR101957657B1 (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분

Publications (1)

Publication Number Publication Date
KR20130091321A true KR20130091321A (ko) 2013-08-16

Family

ID=43587415

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137003073A Ceased KR20130091321A (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분
KR1020187019307A Active KR101957657B1 (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020187019307A Active KR101957657B1 (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분

Country Status (13)

Country Link
US (1) US20130098286A1 (https=)
EP (1) EP2591350B1 (https=)
JP (1) JP5916723B2 (https=)
KR (2) KR20130091321A (https=)
CN (1) CN103119435A (https=)
AU (1) AU2011281482B2 (https=)
CA (1) CA2802402A1 (https=)
ES (1) ES2609831T3 (https=)
FR (1) FR2962550B1 (https=)
IL (1) IL223886B (https=)
MX (1) MX344783B (https=)
WO (1) WO2012010765A1 (https=)
ZA (1) ZA201300099B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104237224A (zh) * 2014-10-14 2014-12-24 厦门奥亚仪器有限公司 苯二氮卓的快速检测方法及其操作器皿组合
US20220202742A1 (en) * 2019-05-07 2022-06-30 Clexio Biosciences Ltd. Dosage forms for preventing drug-facilitated assault
US20220241238A1 (en) * 2020-10-24 2022-08-04 Michael Roth Method for forming a beverage with a dissolvable thc tablet
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
CN115112582B (zh) * 2022-05-19 2024-08-09 西南科技大学 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法
CN117654708A (zh) * 2023-10-16 2024-03-08 杭州德望纳米科技有限公司 一种基于球磨实验改变蛇纹石粒度分级方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157662A (en) * 1966-08-08 1969-07-09 Codex S A Improvements in or relating to Pharmaceutical Compositions
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
US6617123B1 (en) * 2000-06-29 2003-09-09 Jack V. Smith Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
ITMI20011446A1 (it) * 2001-07-06 2003-01-06 Altergon Sa Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
US20030044989A1 (en) * 2001-09-04 2003-03-06 Guerra Francisco Javier Apparatus and method for testing a beverage for a clandestine illicit substance
FR2829932B1 (fr) * 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2831820B1 (fr) 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
WO2005059541A1 (en) 2003-12-19 2005-06-30 Bloomsbury Innovations Ltd. Apparatus for detecting drugs in a beverage
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
JP2009256295A (ja) * 2008-04-11 2009-11-05 Kosumedei Seiyaku Kk 化粧用粘着シート
JP5059678B2 (ja) * 2008-04-18 2012-10-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 着色固形製剤およびその製造方法
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre

Also Published As

Publication number Publication date
AU2011281482A1 (en) 2013-01-17
WO2012010765A1 (fr) 2012-01-26
KR101957657B1 (ko) 2019-03-12
JP2013530206A (ja) 2013-07-25
ZA201300099B (en) 2014-03-26
EP2591350B1 (fr) 2016-10-26
AU2011281482B2 (en) 2015-10-01
ES2609831T3 (es) 2017-04-24
KR20180080374A (ko) 2018-07-11
CA2802402A1 (fr) 2012-01-26
FR2962550B1 (fr) 2013-06-14
US20130098286A1 (en) 2013-04-25
MX344783B (es) 2017-01-06
EP2591350A1 (fr) 2013-05-15
CN103119435A (zh) 2013-05-22
JP5916723B2 (ja) 2016-05-11
FR2962550A1 (fr) 2012-01-13
MX2012015103A (es) 2013-05-28
IL223886B (en) 2018-03-29

Similar Documents

Publication Publication Date Title
EP1194132B1 (en) Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
KR101957657B1 (ko) 음료 내의 약물을 검출하기 위한 방법 및 성분
AU2011278140B2 (en) Pharmaceutical form for combating chemical submission of a medicament
JP5960159B2 (ja) 誤用を防止することを目的とする経口投与用医薬組成物
JP5960158B2 (ja) ゾルピデムベースの口腔内崩壊医薬錠剤
HK1184219A (zh) 用於检测饮料中的药物的方法和试剂
HK1184050B (en) Pharmaceutical form for combating chemical submission of a medicament

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130205

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150818

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170915

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180329

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170915

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180329

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20171115

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20150818

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20180604

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20180430

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20180329

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20171115

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20170915

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20150818

X601 Decision of rejection after re-examination
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20180705